Scholars Central

Research articlePublished 30 Jan 2023

Left Ventricular End Systolic Volume as an Indicator of Remodelling after Myocardial Necrosis after the Spect Examination with Technetium Tetrofosmin Drug

Authors: Hilfan AP Lubis, Manoefris Kasim, Elen Sahara, Celly A Atmadikoesoemah

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Left Ventricular End Systolic Volume (LVESV) is one of the parameters to assess left ventricular function other than ejection fraction. The LVESV value is an indicator of remodelling after myocardial necrosis and has been shown to have prognostic value in post-infarction patients. Research on the relationship between end systolic volume and mortality or major cardiovascular events has been carried out in post-infarction patients. Similar studies in the population of stable angina pectoris have not been widely carried out. Objective: To determine the prognostic role of LVESV in predicting major cardiovascular events (MACE) and determine the median LVESV value that can predict MACE in patients with stable CHD. Research methods: The study was conducted using a retrospective cohort method on 103 stable CHD patients without a history of infarction or revascularization who underwent SPECT Tc99m tetrofosmin examination at the nuclear department of the Harapan Kita National Heart Center from January 2017 to June 2018 which will be followed for 6 months unless MACE occurs. Results: The numbers of subjects analyzed in this study were 103 patients. During the observation period there were a total of 29 patients (28.2%) who experienced major cardiovascular events. Patients who experienced MACE had a higher LVESV value (190.31 ± 115.63 mL vs 105.76 ± 80.44 mL) when compared to patients who did not experience MACE (p=0.001). The results of the bivariate analysis showed that the final systolic volume was statistically significant. The results of cox regression analysis showed that the final systolic volume value of ≥ 113mL was a predictor of major cardiovascular events in patients with stable coronary heart disease with hazard ratio 3,753 (CI 1.595-8,855; p value=0.001). Conclusion: End systolic volume (ESV) is one of the significant independent predictors of MACE. The value of the end systolic volume (ESV) of ≥113 mL has a predictor value for the occurrence of MACE.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Drug and Alcohol Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Drug and Alcohol Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Hilfan AP Lubis”
  • BylineArticles whose byline prints “Manoefris Kasim”
  • BylineArticles whose byline prints “Elen Sahara”
  • BylineArticles whose byline prints “Celly A Atmadikoesoemah”